If you are a doctor, researcher or a licensed practitioner that uses or studies bacteriophages and would like to share your work, send us an email on research@bacteriophage.news.
Dr. Swapnil Ganesh Sanmukh shares an overview on the research focused on bacteriophages targeting biofilms in-vivo as natural enzyme-linked nanoparticles.
A prediction model for phage therapy efficacy by researchers from Inserm, Université Sorbonne Paris Nord and Université Paris-Cité at the IAME Laboratory.
Research into cognition and the presence of Caudovirales bacteriophages in gut microbiota has expanded the interest of the gut microbiome beyond bacteria.
Research into the gut microbiota shows potential for phage therapy against Ruminococcus gnavus, found in Hidradenitis suppurativa (HS), Inflammatory Bowel Disease (IBD); Crohn’s disease, and Ulcerative Colitis (UC) patients.
Trained bacteriophages show effectiveness against resistant bacteria, project by Joshua Borin from UC San Diego.
Synthetic bacteriophages with shortened genome created successfully by scientists from CEB – Centre of Biological Engineering, Braga in Portugal.
Research shows an opportunity in using a combination of bacteriophages with antibiotics against superbugs.
As more research is conducted to learn about the Coronavirus, phage therapy may hold some answers.
CBASS or the self-destruct mechanism is another immune mechanism that bacteria utilize against bacteriophage.
Lysogeny in Temperate Bacteriophages is diverse and many factors are taken into consideration. This article takes a deeper view on lysogeny and phages.